דלאצין סי כמוסות 300 מג

País: Israel

Língua: hebraico

Origem: Ministry of Health

Ingredientes ativos:

CLINDAMYCIN HYDROCHLORIDE

Disponível em:

PFIZER PFE PHARMACEUTICALS ISRAEL LTD

Código ATC:

J01FF01

Forma farmacêutica:

קפסולות

Composição:

CLINDAMYCIN HYDROCHLORIDE 300 MG

Via de administração:

פומי

Tipo de prescrição:

מרשם נדרש

Fabricado por:

FAREVA AMBOISE, FRANCE

Grupo terapêutico:

CLINDAMYCIN

Área terapêutica:

CLINDAMYCIN

Indicações terapêuticas:

Treatment of infections caused by susceptible anaerobic bacteria.

Data de autorização:

2021-05-31

Folheto informativo - Bula

Dalacin C capsules PIL CC 121023
2023-0088338
1
) (
"
-
1986
™
150 "
™
300 "
:
150
"
,
300
"
Clindamycin hydrochloride 150 mg, 300 mg)
(
:
2
"
"
6
"
"
.
.
.
,
.
.
.
.
1
. ?
-
.
:
.
2
.
:
)
(
,
)
6
.( ,
:

,
.

.

)
,
,
(
.
:

,
,
Clostridium
difficile (CDAD)
.
.

.
.
.

,
)
3
"
?
("
,
.
,
,
.
60
.
, ,
.
:

.

CYP3A4
CYP3A5
,
.
Dalacin C capsules PIL CC 121023
2023-0088338
2
.
)
(
.
,
.
™
,
.
.
.
,
.
3
. ?
.
.
.
.
,
-
30
.
.
,
.
.
,
.
.
.
,
.
,
"
™
.
.
. ! .
. ,
.
4
.
,
.
,
.
:

)
.(
,
.
.

-
,
,
,
,
,
)
,
.(
.

,
,
,
,
,
.

)
.(
:
Dalacin C capsules PIL CC 121023
2023-0088338
3

,
,
)
(
,
)
(
,
,
:
,
,
,
(
)
,
-
)
(
,
,
,
,
,
)
,
/
(
,
,
,
, ,
,
,
.
, ,
.
"
"
)
l
ov.i
lth.g
www.hea
(
"
,
:
il
gov.
cts.health.
deeffe
si
/
/
:
https
5
.
?

!
/
.
.

)
(exp. date
.
.

-
°C
25
.
6
.
,
:
150
:"
Lactose, gelatin, maize starch, talc, magnesium stearate and titanium
dioxide (E171).
300
:"
Lactose, gelatin, maize starch, magnesium stearate, talc, titanium
dioxide (E171),
erythrosine (E127) and indigo carmine (E132).
:
150
"
:
-
.5
209
. "
300
"
:
-
254
. "
:
150
:"
'
"
Pfizer
"
-
"
CLIN150
"
.
300
"
:
'
"
Pfizer
"
-
"
CLIN300
"
.
16
-
100
.
.
:
,"
'
9
,
46725
.
:
™
150
:"
5
9
95.248
019
™
00
3
:"
.03.28594
105
,
.
,
.
-
10/2023
.